Safety and Feasibility of Neoadjuvant-Modified FOLFIRINOX in Elderly Patients with Pancreatic Cancer.

Autor: Shindo, Yoshitaro1 (AUTHOR) y.shindo@yamaguchi-u.ac.jp, Ioka, Tatsuya2 (AUTHOR) ioka64t@yamaguchi-u.ac.jp, Tokumitsu, Yukio1 (AUTHOR) yt790604@yamaguchi-u.ac.jp, Matsui, Hiroto1 (AUTHOR) matsui-h@yamaguchi-u.ac.jp, Nakajima, Masao1 (AUTHOR) masao-y@yamaguchi-u.ac.jp, Kimura, Yuta1 (AUTHOR) ykimura@yamaguchi-u.ac.jp, Watanabe, Yusaku1 (AUTHOR) yusakuw@yamaguchi-u.ac.jp, Tomochika, Shinobu1 (AUTHOR) bu-shino@yamaguchi-u.ac.jp, Nakagami, Yuki3 (AUTHOR) nakagami-yu@shimonoseki-cu.ac.jp, Tsunedomi, Ryouichi1 (AUTHOR) tsune-r@yamaguchi-u.ac.jp, Iida, Michihisa1 (AUTHOR) miida@yamaguchi-u.ac.jp, Takahashi, Hidenori1 (AUTHOR) hdnrtkhs@yamaguchi-u.ac.jp, Nagano, Hiroaki1 (AUTHOR) hnagano@yamaguchi-u.ac.jp
Zdroj: Cancers. Jul2024, Vol. 16 Issue 14, p2522. 12p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje